Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
1,447

Quick answer

1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8980921

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8980899

    Methods of inhibiting Ire1

    The Regents of the University of California · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8980302

    Therapeutic implant

    Covidien LP · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8980304

    Barrel-shaped vaginal ring

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8980608

    High molecular weight heparosan polymers and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8980258

    Bispecific single chain Fv antibody molecules and methods of use therof

    The Regents of the University of California · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8980902

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8980343

    Plant extract, compositions containing same, method of extraction and uses thereof

    Botanic Century (Beijing) Co. Ltd. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8980838

    Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8980322

    Controlled release composition

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8979831

    Thermochemical ablation system using heat from delivery of electrophiles

    Regents of the University of Minnesota · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8980836

    Method of treating degenerative disorders of the nervous system

    The Regents of the University of California · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8980266

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8980268

    Methods for treating cancer by administering an anti-Ang-2 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8980275

    Targeted heterologous antigen presentation on calicivirus virus-like particles

    Takeda Vaccines, Inc. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8980822

    Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8980549

    MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. EP 2847225

    ANTIKÖRPER GEGEN CLAUDIN 18.2 FÜR DIE KREBSDIAGNOSE

    GANYMED PHARMACEUTICALS AG [DE] · Granted Wed Mar 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Mar 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. EP 2846808

    ZUCKERZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HÄMOPHILIE A UND/ODER VON-WILLEBRAND-SYNDROM

    CSL BEHRING GMBH [DE] · Granted Wed Mar 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Mar 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2015036507

    UTILISATION DE CABAZITAXEL CHEZ DES PATIENTS CHEZ QUI UN CANCER DU POUMON NON À PETITES CELLULES MÉTASTATIQUE CONTINUE À PROGRESSER APRÈS UN TRAITEMENT À BASE DE DOCÉTAXEL

    AVENTIS PHARMA SA [FR] · Granted Thu Mar 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8986708

    Combinations of gene deletions for live attenuated Shigella vaccine strains

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8986701

    Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8986736

    Method for delivering particulate drugs to tissues

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8986688

    WAP domain fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8986757

    Essential oils inhibit mold on wood

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8986935

    Methods for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8987227

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8987216

    Polysulfated glycosides and salts thereof

    Teva Hungary Pharmaceutical Marketing Private Limited Company · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8987198

    Compositions and methods for treating obesity and diabetes

    United States Department of Agriculture · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8987192

    Potent and selective mediators of cholesterol efflux

    The Regents of the University of California · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8987228

    Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

    CAN-FITE BIOPHARMA LTD. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8987377

    Poly(amide) polymers for the delivery of oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8987296

    Acridone compounds

    The United States of America DBA The Department of Veterans Affairs · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8987309

    Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8987308

    Compounds for the treatment of Clostridium difficile-associated disease

    Summit Corporation Plc · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8987426

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8987294

    Small molecule inhibitors of the α4-paxillin interaction

    The Regents of the University of California · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8987289

    Methods for treating pruritus

    Trevi Therapeutics, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8987332

    Methods of treating inflammatory conditions

    The Regents of the University of California · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8989847

    Method of measuring propulsion in lymphatic structures

    The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8987189

    Treating hepatitis C virus infection

    The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8987303

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8986005

    Strip for transferring a therapeutic composition to a tooth

    DISCUS DENTAL, LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8987454

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8987420

    High affinity human antibodies to human angiopoietin-2

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8987305

    2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

    APTOSE BIOSCIENCES INC. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8987238

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8987237

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.